Powers 2016.
Trial name or title | Efficacy of smoking cessation therapy alone or integrated with prolonged exposure therapy for smokers with PTSD |
Methods | Study design: randomised controlled trial Setting: USA Recruitment: smokers with post‐traumatic stress disorder aged between 18 and 64 years selected for motivation to quit |
Participants | 80 participants |
Interventions | Pharmacotherapy: nicotine patch 1. Standard smoking cessation treatment: once‐weekly 45‐minute sessions of cognitive behavioural therapy over a 12‐week period 2. Integrated PTSD and smoking treatment: once‐weekly 90‐minute sessions over a 12‐week period. Incorporated standard treatment with therapy for reducing PTSD symptoms and anxiety sensitivity and enhancing tolerance for nicotine withdrawal sensations. |
Outcomes | Abstinence at 24 weeks Validation: saliva cotinine < 10ng/mL for stated abstinence of 2 weeks or more, carbon monoxide analysis of breath samples < 8ppm for stated abstinence of 24 hours to 2 weeks |
Starting date | October 2013 |
Contact information | Mark B Powers, University of Texas |
Notes |